Growth Equity Opportunities Fund, LLC

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$6.55M
Insider Sells Quantity
5
Insider Sells Sum
$6.84M

Insider Activity of Growth Equity Opportunities Fund, LLC

The largest purchase of all time was on 2010-06-30 and amounted to 23824451 share of Viracta Therapeutics, Inc. for $6.55M.

The largest sale of all time was on 2014-08-08 and amounted to 675000 shares of Viracta Therapeutics, Inc. for $4.47M.

Biography of Growth Equity Opportunities Fund, LLC

No biography is available at this moment.

2014-08-29SaleViracta Therapeutics, Inc.
VIRX
10 percent owner
11,600
0.0192%
$7.51$87,070-68.09%
2014-08-28SaleViracta Therapeutics, Inc.
VIRX
10 percent owner
146,800
0.2452%
$7.87$1.15M-69.28%
2014-08-27SaleViracta Therapeutics, Inc.
VIRX
10 percent owner
108,300
0.1776%
$8.17$884,811-70.96%
2014-08-12SaleViracta Therapeutics, Inc.
VIRX
10 percent owner
35,540
0.0589%
$6.76$240,190-63.95%
2014-08-08SaleViracta Therapeutics, Inc.
VIRX
10 percent owner
675,000
1.1015%
$6.62$4.47M-63.58%
2010-06-30PurchaseViracta Therapeutics, Inc.
VIRX
10 percent owner
23.82M
6.2843%
$0.28$6.55M-14.89%
2009-10-30PurchaseViracta Therapeutics, Inc.
VIRX
10 percent owner
333,166
–
$0$0+62.16%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.